Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coleman Smith

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The New England Journal of Medicine|September 27, 2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infectionMichael W Fried, Mitchell L Shiffman, K Rajender Reddy, et al.
Transplantation|October 22, 2024
Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH ConsortiumSanjaya K Satapathy, Saleh Elwir, Danielle Brandman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2026
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 LevelsShehnaz K Hussain, Walid S Ayoub, Marcia Cruz-Correa, et al.
Transplantation|October 31, 2025
The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in SpainLaura Martínez-Arenas, Ângela Carvalho-Gomes, Enrique Vidal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH ConsortiumMary E Rinella, Sanjaya K Satapathy, Danielle Brandman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplantMarion G Peters, Shyam Kottilil, Norah Terrault, et al.
The American Journal of Gastroenterology|July 12, 2024
The Survival Benefit of Reabstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multicenter ACCELERATE StudyMatthew Dukewich, Jennifer L Dodge, Michael R Lucey, et al.
Gastroenterology|December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis BJang-June Park, David K Wong, Abdus S Wahed, et al.
Physical Review Letters|November 4, 2022
β-Delayed One and Two Neutron Emission Probabilities Southeast of ^{132}Sn and the Odd-Even Systematics in r-Process Nuclide AbundancesV H Phong, S Nishimura, G Lorusso, et al.
Physical Review Letters|August 20, 2016
Superdeformed and Triaxial States in ^{42}CaK Hadyńska-Klȩk, P J Napiorkowski, M Zielińska, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The New England Journal of Medicine|September 27, 2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infectionMichael W Fried, Mitchell L Shiffman, K Rajender Reddy, et al.
Transplantation|October 22, 2024
Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH ConsortiumSanjaya K Satapathy, Saleh Elwir, Danielle Brandman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2026
Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 LevelsShehnaz K Hussain, Walid S Ayoub, Marcia Cruz-Correa, et al.
Transplantation|October 31, 2025
The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in SpainLaura Martínez-Arenas, Ângela Carvalho-Gomes, Enrique Vidal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH ConsortiumMary E Rinella, Sanjaya K Satapathy, Danielle Brandman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplantMarion G Peters, Shyam Kottilil, Norah Terrault, et al.
The American Journal of Gastroenterology|July 12, 2024
The Survival Benefit of Reabstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multicenter ACCELERATE StudyMatthew Dukewich, Jennifer L Dodge, Michael R Lucey, et al.
Gastroenterology|December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis BJang-June Park, David K Wong, Abdus S Wahed, et al.
Physical Review Letters|November 4, 2022
β-Delayed One and Two Neutron Emission Probabilities Southeast of ^{132}Sn and the Odd-Even Systematics in r-Process Nuclide AbundancesV H Phong, S Nishimura, G Lorusso, et al.
Physical Review Letters|August 20, 2016
Superdeformed and Triaxial States in ^{42}CaK Hadyńska-Klȩk, P J Napiorkowski, M Zielińska, et al.
Pageof 3